BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21675926)

  • 1. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey.
    Dunkel P; Balogh B; Meleddu R; Maccioni E; Gyires K; Mátyus P
    Expert Opin Ther Pat; 2011 Sep; 21(9):1453-71. PubMed ID: 21675926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
    Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
    J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
    O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
    J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PXS-4681A, a potent and selective mechanism-based inhibitor of SSAO/VAP-1 with anti-inflammatory effects in vivo.
    Foot JS; Yow TT; Schilter H; Buson A; Deodhar M; Findlay AD; Guo L; McDonald IA; Turner CI; Zhou W; Jarolimek W
    J Pharmacol Exp Ther; 2013 Nov; 347(2):365-74. PubMed ID: 23943052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSAO inhibitors suppress hepatocellular tumor growth in mice.
    Li R; Li H; Luo HJ; Lin ZX; Jiang ZW; Luo WH
    Cell Immunol; 2013; 283(1-2):61-9. PubMed ID: 23850964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
    Carpéné C; Bizou M; Tréguer K; Hasnaoui M; Grès S
    J Physiol Biochem; 2015 Sep; 71(3):487-96. PubMed ID: 25572340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema.
    Inoue T; Morita M; Tojo T; Yoshihara K; Nagashima A; Moritomo A; Ohkubo M; Miyake H
    Bioorg Med Chem; 2013 Mar; 21(5):1219-33. PubMed ID: 23337801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of human semicarbazide-sensitive amine oxidase/vascular adhesion protein-1.
    Jakobsson E; Nilsson J; Ogg D; Kleywegt GJ
    Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1550-62. PubMed ID: 16239734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress.
    Yegutkin GG; Salminen T; Koskinen K; Kurtis C; McPherson MJ; Jalkanen S; Salmi M
    Eur J Immunol; 2004 Aug; 34(8):2276-85. PubMed ID: 15259025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
    Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY
    Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis.
    O'Rourke AM; Wang EY; Salter-Cid L; Huang L; Miller A; Podar E; Gao HF; Jones DS; Linnik MD
    J Neural Transm (Vienna); 2007; 114(6):845-9. PubMed ID: 17393060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
    Stolen CM; Madanat R; Marti L; Kari S; Yegutkin GG; Sariola H; Zorzano A; Jalkanen S
    FASEB J; 2004 Apr; 18(6):702-4. PubMed ID: 14977883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
    Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
    Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
    Yraola F; García-Vicente S; Fernandez-Recio J; Albericio F; Zorzano A; Marti L; Royo M
    J Med Chem; 2006 Oct; 49(21):6197-208. PubMed ID: 17034126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
    Sun P; Solé M; Unzeta M
    Cerebrovasc Dis; 2014; 37(3):171-80. PubMed ID: 24503888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic polyamines as potential amine oxidase inhibitors: a preliminary study.
    Emanuela B; Minarini A; Tumiatti V; Milelli A; Lunelli M; Pegoraro M; Rizzoli V; Di Paolo ML
    Amino Acids; 2012 Feb; 42(2-3):913-28. PubMed ID: 21858471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity.
    Wang EY; Gao H; Salter-Cid L; Zhang J; Huang L; Podar EM; Miller A; Zhao J; O'rourke A; Linnik MD
    J Med Chem; 2006 Apr; 49(7):2166-73. PubMed ID: 16570912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioluminescent method for assaying multiple semicarbazide-sensitive amine oxidase (SSAO) family members in both 96- and 384-well formats.
    Peet GW; Lukas S; Hill-Drzewi M; Martin L; Rybina IV; Roma T; Shoultz A; Zhu X; Cazacu D; Kronkaitis A; Baptiste A; Raudenbush BC; August EM; Modis LK
    J Biomol Screen; 2011 Oct; 16(9):1106-11. PubMed ID: 21844327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis.
    Noda K; Miyahara S; Nakazawa T; Almulki L; Nakao S; Hisatomi T; She H; Thomas KL; Garland RC; Miller JW; Gragoudas ES; Kawai Y; Mashima Y; Hafezi-Moghadam A
    FASEB J; 2008 Apr; 22(4):1094-103. PubMed ID: 18032635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration.
    Schilter HC; Collison A; Russo RC; Foot JS; Yow TT; Vieira AT; Tavares LD; Mattes J; Teixeira MM; Jarolimek W
    Respir Res; 2015 Mar; 16(1):42. PubMed ID: 25889951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.